April - 2022

Companies in the News

Apr 19, 2022

Tessera Therapeutics Announces Over $300M Series C Financing to Advance its GENE WRITING Platform

SOMERVILLE, Mass.--(BUSINESS WIRE)--Tessera Therapeutics, the biotechnology company pioneering a new approach in genetic medicine known...

Apr 12, 2022

Ansa Biotechnologies Closes Oversubscribed $68 Million Series A Financing

Ansa’s next-generation enzymatic DNA synthesis technology will dramatically accelerate innovation across every industry enabled by...